|
|
Article: CancerVax Travels To Cuba To Expand Cancer Pipeline.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
CancerVax Corp. completed a historic licensing deal, of sorts, gaining access to a Phase II cancer product and a pair of preclinical candidates that originated at Cimab SA, a Cuban biotech company.
The deal took more than a year and a half to complete, given the complexity of working within the framework of the U.S. trade embargo on the communist island, and dealing with YM Biosciences Inc., a third party already involved with the Cuban firm. But in the end, CancerVax significantly expanded its portfolio.
The Carlsbad, Calif.-based company said its wholly owned subsidiaries, Tarcanta Inc. and Tarcanta Ltd. in Ireland, ...